Atlas FDA

G4 Insulin Pump with Dexcom G4 Platinum CGM System

FDA premarket approval P140015/S022 · decided 2017-06-15

Approval details

PMA number
P140015
Supplement
S022
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
G4 Insulin Pump with Dexcom G4 Platinum CGM System
Generic name
Pump, infusion, insulin, to be used with invasive glucose sensor
Applicant
Tandem Diabetes Care, Inc.
Date received
2017-05-16
Decision date
2017-06-15
Days to decision
30 days
Decision code
OK30
Product code
OYC
Advisory committee
Clinical Chemistry
Expedited review
No
Location
San Diego, CA
Statement
Modification to add a QC Manufacturing Aid to complement Quality Control acceptance review during the manufacturing of the t:slim G4 insulin pump, intended to be used with Dexcom G4 Continuous Glucose Monitoring (CGM) sensor and transmitter.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Control-IQ+ technology (K260429)Tandem Diabetes Care, Inc.2026-04-24
Tandem Mobi insulin pump with interoperable technology (K253074)Tandem Diabetes Care, Inc.2025-11-06
t:slim X2 insulin pump with interoperable technology (K250792)Tandem Diabetes Care, Inc.2025-09-24
Control-IQ+ technology (K250798)Tandem Diabetes Care, Inc.2025-05-21
Control-IQ+ technology (K243823)Tandem Diabetes Care, Inc.2025-02-24
Tandem Mobi Insulin Pump with interoperable technology (K241078)Tandem Diabetes Care, Inc.2024-07-26
Tandem Mobi insulin pump with interoperable technology (K240309)Tandem Diabetes Care, Inc.2024-03-21
t:slim X2 Insulin Pump with Interoperable Technology (K232380)Tandem Diabetes Care, Inc.2023-11-03